Patient support data that is trusted, connected and delivered into field workflows can move access teams from reporting to faster patient intervention.
News|Articles|September 25, 2026
Why Retail Pharmacy’s Trust Challenge Is Also Its Path Forward
Author(s)Tim Cernohous
As patient expectations continue to evolve, brick-and-mortar pharmacy’s path forward lies in combining trusted, face-to-face care with the efficiency and convenience patients increasingly value.
Advertisement
Advertisement
Retail pharmacy is at an inflection point. Trust still matters, but it no longer stands on its own as a differentiator. The recent JD Power 2026 U.S. Pharmacy Study underscores that shift, finding that customer satisfaction with brick-and-mortar pharmacies declined seven points year over year, while mail-order satisfaction continued to rise.1 The results point to a widening gap between what patients expect today — convenience, ease, consistency and value — and what many retail pharmacy experiences deliver.
Related to this article
As more pharmacies dispense GLP-1s, payment processor reviews, higher fees and account closures are emerging as an overlooked point of friction in the access channel.
Waltz Health and Fresenius Kabi will offer three biosimilars through a direct-to-payer model that bypasses traditional wholesaler and PBM rebate channels.
At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.
Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner SOPs matter.
At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
Advertisement
Advertisement